Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade B 15.55 4.01% 0.60
AUPH closed up 4.01 percent on Friday, September 18, 2020, on 73 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical AUPH trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Overbought Stochastic Strength 4.01%
Narrow Range Bar Range Contraction 3.94%
NR7 Range Contraction 3.94%
NR7-2 Range Contraction 3.94%
Overbought Stochastic Strength 3.94%
Narrow Range Bar Range Contraction 4.29%
Older End-of-Day Gignals for AUPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits 1 day ago
Rose Above Upper Bollinger Band 2 days ago
Up 3% 2 days ago
Up 1 ATR 2 days ago
Up 2% 2 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Medicine Biopharmaceutical Life Sciences Drugs Autoimmune Diseases Peptides Immunosuppressants Lupus Lupus Nephritis Treatment Of Lupus

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.93
52 Week Low 3.52
Average Volume 1,672,667
200-Day Moving Average 16.31
50-Day Moving Average 14.36
20-Day Moving Average 14.38
10-Day Moving Average 14.59
Average True Range 0.57
ADX 11.93
+DI 29.82
-DI 18.18
Chandelier Exit (Long, 3 ATRs ) 13.85
Chandelier Exit (Short, 3 ATRs ) 14.80
Upper Bollinger Band 15.47
Lower Bollinger Band 13.29
Percent B (%b) 1.04
BandWidth 15.16
MACD Line 0.19
MACD Signal Line 0.04
MACD Histogram 0.1522
Fundamentals Value
Market Cap 1.3 Billion
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -11.96
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.51
Resistance 3 (R3) 16.41 15.98 16.35
Resistance 2 (R2) 15.98 15.74 16.03 16.30
Resistance 1 (R1) 15.77 15.59 15.87 15.87 16.24
Pivot Point 15.34 15.34 15.40 15.40 15.34
Support 1 (S1) 15.13 15.10 15.24 15.23 14.86
Support 2 (S2) 14.70 14.95 14.76 14.80
Support 3 (S3) 14.49 14.70 14.75
Support 4 (S4) 14.59